Sesti, Giorgio

Sesti, Giorgio  

DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE  

Mostra prodotti
Risultati 1 - 20 di 373 (tempo di esecuzione: 0.037 secondi).
Titolo Data di pubblicazione Autore(i) File
3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients 2014 Sciacqua, A; Presta, I; Perticone, M; Tassone, Ej; Andreozzi, F; Quitadamo, Mc; Sangiuolo, Fc; Sesti, G; Perticone,
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study 2008 Staiger, H; Stan, ; Áková, A; Zilinskaite, J; Vänttinen, M; Hansen, T; Marini, Ma; Hammarstedt, A; Jansson, P-A; Sesti, G; Smith, U; Pedersen, O; Laakso, M; Stefan, N; Fritsche, A; Häring, H-U
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 2003 Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R
A fasting insulin–raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. 2013 Mannino, Gc; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, Ma; Perticone, F; Sesti, G
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease 2013 Sesti, G; Mannino, Gc; De Lorenzo, C; Greco, A; Sciacqua, A; Marini, Ma; Andreozzi, F; Perticone, F.
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity 2012 Andreozzi, F; Presta, I; Mannino, Gc; Scarpelli, D; Di Silvestre, S; Di Pietro, N; Succurro, E; Sciacqua, A; Pandolfi, A; Consoli, A; Hribal, Ml; Perticone, F; Sesti, G
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. 2014 Sesti, G; Mannino, Gc; Andreozzi, F; Greco, A; Perticone, M; Sciacqua, A; Marini, Ma; Perticone, F
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus 2009 Montanya, E; Sesti, G
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults. A Meta-analysis 2021 Ahuja, Vasudha; Aronen, Pasi; Pramodkumar, T A; Looker, Helen; Chetrit, Angela; Bloigu, Aini H; Juutilainen, Auni; Bianchi, Cristina; La Sala, Lucia; Anjana, Ranjit Mohan; Pradeepa, Rajendra; Venkatesan, Ulagamadesan; Jebarani, Sarvanan; Baskar, Viswanathan; Fiorentino, Teresa Vanessa; Timpel, Patrick; Defronzo, Ralph A; Ceriello, Antonio; Del Prato, Stefano; Abdul-Ghani, Muhammad; Keinänen-Kiukaanniemi, Sirkka; Dankner, Rachel; Bennett, Peter H; Knowler, William C; Schwarz, Peter; Sesti, Giorgio; Oka, Rie; Mohan, Viswanathan; Groop, Leif; Tuomilehto, Jaakko; Ripatti, Samuli; Bergman, Michael; Tuomi, Tiinamaija
Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser(307) and Ser(612) and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells 2004 Andreozzi, F; D'Alessandris, C; Federici, M; Laratta, E; Del Guerra, S; Del Prato, S; Marchetti, P; Lauro, R; Perticone, F; Sesti, G
Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients 2016 Perticone, M; Cimellaro, A; Maio, R; Caroleo, B; Sciacqua, A; Sesti, G; Perticone, F
Alkaline phosphatase affects renal function in never-treated hypertensive patients. effect modification by age 2020 Sciacqua, Angela; Tripepi, Giovanni; Perticone, Maria; Cassano, Velia; Fiorentino, Teresa V.; Pititto, Gerardo N.; Maio, Raffaele; Miceli, Sofia; Andreozzi, Francesco; Sesti, Giorgio; Perticone, Francesco
ALTERED EXPRESSION OF THE 2 NATURALLY-OCCURRING HUMAN INSULIN-RECEPTOR VARIANTS IN ISOLATED ADIPOCYTES OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS 1991 Sesti, G; Marini, Ma; Tullio, An; Montemurro, A; Borboni, P; Fusco, A; Accili, D; Lauro, R
Altered Insulin Receptor Signalling and β-Cell Cycle Dynamics in Type 2 Diabetes Mellitus 2011 Folli, F; Okada, T; Perego, C; Gunton, J; Liew CW Akiyama, M; D'Amico, A; La Rosa, S; Placidi, C; Lupi, R; Marchetti, P; Sesti, G; Hellerstein, M; Perego, L; Kulkarni, Rn
ALTERED PATTERN OF INSULIN-RECEPTOR ISOTYPES IN SKELETAL-MUSCLE MEMBRANES OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS 1993 Kellerer, M; Sesti, G; Seffer, E; Obermaierkusser, B; Pongratz, De; Mosthaf, L; Haring, Hu
ANDROGENS INCREASE INSULIN-RECEPTOR MESSENGER-RNA LEVELS, INSULIN BINDING, AND INSULIN RESPONSIVENESS IN HEP-2 LARYNX-CARCINOMA CELLS 1992 Sesti, G; Marini, Ma; Briata, P; Tullio, An; Montemurro, A; Borboni, P; Depirro, R; Gherzi, R; Lauro, R
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs 2013 Tassone, E. J.; Sciacqua, A.; Andreozzi, F.; Presta, I.; Perticone, M.; Carnevale, Daniela; Casaburo, M.; Hribal, M. L.; Sesti, G.; Perticone, F.
Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser(312) and Ser(616) in human umbilical vein endothelial cells 2004 Andreozzi, F; Laratta, E; Sciacqua, A; Perticone, F; Sesti, G
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs 2011 Ivan, Presta; E., Joseph Tassone; Francesco, Andreozzi; Maria, Perticone; Angela Laino Irma, Sciacqua; Irma, Laino; Donatella, Musca; Martino, Francesco; Giorgio, Sesti; Francesco, Perticone; Sesti, Giorgio
ANTIBODIES DIRECTED TO THE INSULIN-RECEPTOR - CLINICAL ASPECTS AND APPLICATIONS TO THE STUDY OF INSULIN ACTION 1990 Depirro, R; Borboni, P; Marini, Ma; Montemurro, A; Sesti, G; Lauro, R